BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 21242849)

  • 1. Ophthalmic complications following treatment of paranasal sinus rhabdomyosarcoma in comparison to orbital disease.
    Gandhi PD; Fleming JC; Haik BG; Wilson MW
    Ophthalmic Plast Reconstr Surg; 2011; 27(4):241-6. PubMed ID: 21242849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visual outcomes and late complications in paediatric orbital rhabdomyosarcoma.
    Eade E; Tumuluri K; Do H; Rowe N; Smith J
    Clin Exp Ophthalmol; 2017 Mar; 45(2):168-173. PubMed ID: 27473389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multidisciplinary treatment of primary orbital rhabdomyosarcoma. A single-institution experience.
    Fiorillo A; Migliorati R; Grimaldi M; Vassallo P; Canale G; Tranfa F; Uccello G; Fiore M; Muto P; Menna G
    Cancer; 1991 Feb; 67(3):560-3. PubMed ID: 1985749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Late effects of therapy in 94 patients with localized rhabdomyosarcoma of the orbit: Report from the Intergroup Rhabdomyosarcoma Study (IRS)-III, 1984-1991.
    Raney RB; Anderson JR; Kollath J; Vassilopoulou-Sellin R; Klein MJ; Heyn R; Glicksman AS; Wharam M; Crist WM; Maurer HM
    Med Pediatr Oncol; 2000 Jun; 34(6):413-20. PubMed ID: 10842248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiation late effects in children treated for orbital rhabdomyosarcoma.
    Fiorillo A; Migliorati R; Vassallo P; Canale G; Tranfa F; Fariello I; De Chiara C; D'Amore R; Muto P; Bonavolontà G
    Radiother Oncol; 1999 Nov; 53(2):143-8. PubMed ID: 10665792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intergroup rhabdomyosarcoma study-IV: results for patients with nonmetastatic disease.
    Crist WM; Anderson JR; Meza JL; Fryer C; Raney RB; Ruymann FB; Breneman J; Qualman SJ; Wiener E; Wharam M; Lobe T; Webber B; Maurer HM; Donaldson SS
    J Clin Oncol; 2001 Jun; 19(12):3091-102. PubMed ID: 11408506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of embryonal rhabdomyosarcoma of the sinus and orbit with chemotherapy, radiation, and endoscopic surgery.
    Luu QC; Lasky JL; Moore TB; Nelson S; Wang MB
    J Pediatr Surg; 2006 Jun; 41(6):e15-7. PubMed ID: 16769322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of orbital rhabdomyosarcoma: survival and late effects of treatment--results of an international workshop.
    Oberlin O; Rey A; Anderson J; Carli M; Raney RB; Treuner J; Stevens MC;
    J Clin Oncol; 2001 Jan; 19(1):197-204. PubMed ID: 11134213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical spectrum of primary ophthalmic rhabdomyosarcoma.
    Shields CL; Shields JA; Honavar SG; Demirci H
    Ophthalmology; 2001 Dec; 108(12):2284-92. PubMed ID: 11733272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Embryonal rhabdomyosarcoma with infiltration of the orbit and the paranasal sinuses (author's transl)].
    Lorenz B; Stefani FH; Haas RJ
    Klin Monbl Augenheilkd; 1982 Feb; 180(2):160-1. PubMed ID: 7087347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adult rhabdomyosarcoma in the nasal and paranasal sinuses showing complete local response to a combination of chemotherapy and radiotherapy using 3D-CRT and IMRT.
    Muto E; Shioyama Y; Nakamura K; Ohga' S; Nomoto S; Toba T; Yoshitake T; Soeda H; Terashima H; Honda H
    Fukuoka Igaku Zasshi; 2005 Oct; 96(10):363-9. PubMed ID: 16408493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Update of orbital rhabdomyosarcoma therapy in children].
    Ducrey N; Nenadov-Beck M; Spahn B
    J Fr Ophtalmol; 2002 Mar; 25(3):298-302. PubMed ID: 11941256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rhabdomyosarcoma of nose and paranasal sinuses--a therapeutic challenge.
    Sinha R; Bandyopadhyay SN; Pathak K; Hati G
    J Indian Med Assoc; 2006 Sep; 104(9):519-21. PubMed ID: 17388011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term evaluation of orbital rhabdomyosarcoma in children.
    Boutroux H; Levy C; Mosseri V; Desjardins L; Plancher C; Helfre S; Freneaux P; Cellier C; Orbach D
    Clin Exp Ophthalmol; 2015; 43(1):12-9. PubMed ID: 24923774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiation therapy for rhabdomyosarcoma of the orbit.
    Sagerman RH; Cassady JR; Tretter P
    Trans Am Acad Ophthalmol Otolaryngol; 1968; 72(6):849-54. PubMed ID: 4177896
    [No Abstract]   [Full Text] [Related]  

  • 16. Management of orbital rhabdomyosarcoma.
    Dayton GO; Langdon E; Rochlin D
    Trans Pac Coast Otoophthalmol Soc Annu Meet; 1969; 50():225-36. PubMed ID: 4924570
    [No Abstract]   [Full Text] [Related]  

  • 17. The role of chemotherapy, surgery, and radiotherapy in rhabdomyosarcoma of the orbit.
    van Manen SR; de Kraker J; Voute PA
    Pediatr Hematol Oncol; 1991; 8(3):273-6. PubMed ID: 1845177
    [No Abstract]   [Full Text] [Related]  

  • 18. Ocular and orbital complications following radiation therapy of paranasal sinus malignancies and review of literature.
    Nakissa N; Rubin P; Strohl R; Keys H
    Cancer; 1983 Mar; 51(6):980-6. PubMed ID: 6336990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary ophthalmic rhabdomyosarcoma in 33 patients.
    Shields CL; Shields JA; Honavar SG; Demirci H
    Trans Am Ophthalmol Soc; 2001; 99():133-42; discussion 142-3. PubMed ID: 11797301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extensive alveolar-type paranasal sinus and orbit rhabdomyosarcoma with intracranial invasion treated successfully.
    Chen SC; Bee YS; Lin MC; Sheu SJ
    J Chin Med Assoc; 2011 Mar; 74(3):140-3. PubMed ID: 21421211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.